K171217 is an FDA 510(k) clearance for the DyeVert Plus Contrast Reduction System, DyeVert NG Contrast Reduction System. This device is classified as a Injector And Syringe, Angiographic (Class II - Special Controls, product code DXT).
Submitted by Osprey Medical, Inc. (Minnetonka, US). The FDA issued a Cleared decision on May 26, 2017, 30 days after receiving the submission on April 26, 2017.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1650.
| 510(k) Number | K171217 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | April 26, 2017 |
| Decision Date | May 26, 2017 |
| Days to Decision | 30 days |
| Submission Type | Special |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXT - Injector And Syringe, Angiographic |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1650 |